Citation 67224

KAMEL,MS: OHTANI,K: KUROKAWA,T: ASSAF,MH: EL-SHANAWANY,MA: ALI,AA: KASAI,R: ISHIBASHI,S: TANAKA,O:. (1991). STUDIES ON BALANITES AEGYPTIACA FRUITS, AN ANTIDIABETIC EGYPTIAN FOLK MEDICINE.. 39(5)

Citation Details

Title	STUDIES ON BALANITES AEGYPTIACA FRUITS, AN ANTIDIABETIC EGYPTIAN FOLK MEDICINE.
Authors	KAMEL,MS: OHTANI,K: KUROKAWA,T: ASSAF,MH: EL-SHANAWANY,MA: ALI,AA: KASAI,R: ISHIBASHI,S: TANAKA,O:
Year	1991
Volume	39
Issue	5

Summary

Year: 1991

Journal: Unknown

Organisms and Their Experiments (2)

Balanites aegyptiaca (ZYGOPHYLLACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
2	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	FUROST-5-ENE-3-BETA-22-26-TRIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 3-O-(2-4-DI-O-ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE	None
4	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROST-5-ENE-3-BETA-22-26-TRIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 3-O-(2-4-DI-O-ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE	INACTIVE
5	Not specified	HPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDQUANTITATIVE DATA	FUROST-5-ENE-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 22-O-METHYL: 3-O-(2-4-DI-O-ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE	None
6	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROST-5-ENE-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 22-O-METHYL: 3-O-(2-4-DI-O-ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE	INACTIVE
7	Not specified	HPLC SEPARATION DATA FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FUROST-5-ENE-3-BETA-22-26-TRIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 3-O-(ALPHA-L-RHAMNOPYRANOSYL(1-2))-(BETA-D-XYLOPYRANOSYL(1-3))-(ALPHA-L-RHAMNOPYRANOSYL(1-4))BETA-D-GLUCOSIDE	None
8	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROST-5-ENE-3-BETA-22-26-TRIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 3-O-(ALPHA-L-RHAMNOPYRANOSYL(1-2))-(BETA-D-XYLOPYRANOSYL(1-3))-(ALPHA-L-RHAMNOPYRANOSYL(1-4))BETA-D-GLUCOSIDE	INACTIVE
9	Not specified	HPLC SEPARATION DATA FORTLC DATA REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FUROST-5-ENE-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 22-O-METHYL: 3-O-ALPHA-L-RHAMNOPYRANOSYL-(1-2))-(BETA-D-XYLOPYRANOSYL(1-3))-ALPHA-L-RHAMNOPYRANOSYL(1-4))BETA-D-GLUCOPYSIDE	None
10	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROST-5-ENE-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 22-O-METHYL: 3-O-ALPHA-L-RHAMNOPYRANOSYL-(1-2))-(BETA-D-XYLOPYRANOSYL(1-3))-ALPHA-L-RHAMNOPYRANOSYL(1-4))BETA-D-GLUCOPYSIDE	INACTIVE
11	Not specified	HPLC SEPARATION DATA FORMASS-SPECTRAL FRAGMENTATION REPORTEDTLC DATA REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CHOLESTADIENE GLYCOSIDE 5	None
12	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	CHOLESTADIENE GLYCOSIDE 5	INACTIVE
13	Not specified	HPLC SEPARATION DATA FORMASS-SPECTRAL FRAGMENTATION REPORTEDTLC DATA REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CHOLESTADIENE GLYCOSIDE 6	None
14	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	CHOLESTADIENE GLYCOSIDE 6	INACTIVE
15	Not specified	HPLC SEPARATION DATA FORMASS-SPECTRAL FRAGMENTATION REPORTEDTLC DATA REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CHOLESTADIENE GLYCOSIDE 7	None
16	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	CHOLESTADIENE GLYCOSIDE 7	INACTIVE
17	Not specified	HPLC SEPARATION DATA FORMASS-SPECTRAL FRAGMENTATION REPORTEDTLC DATA REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CHOLESTADIENE GLYCOSIDE 8	None
18	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	CHOLESTADIENE GLYCOSIDE 8	INACTIVE

Balanites aegyptiaca (ZYGOPHYLLACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	HPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDTLC DATA REPORTEDQUANTITATIVE DATA	RHAMNETIN,ISO: 3-O-RUTINOSIDE	None
2	Not specified	HPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDTLC DATA REPORTEDQUANTITATIVE DATA	RHAMNETIN,ISO: 3-O-ROBINOBIOSIDE	None

Show SPARQL Queries (1)